Vaccine Maker to Film Maker: Serum's Adar Poonawala to invest in Karan Johar's production company MD Bureau21 Oct 2024 3:31 PM ISTSerene Productions has entered into a binding agreement to invest Rs 1,000 crore in production house Dharma Productions and Dharmatic Entertainment...
SII makes strategic investment in IntegriMedical, India's First Needle-Free Injection System Technology Ruchika Sharma17 May 2024 4:09 PM ISTIntegriMedical's Needle-Free Injections System also known as N-FIS has received regulatory approvals from CDSCO, CE, MDSAP and is ISO 13485 certified.
AstraZeneca admits Covishield can cause rare side effects Roshni Dhar1 May 2024 5:12 PM ISTAstraZeneca (AZ), a pharmaceutical giant headquartered in the UK, has acknowledged that in "very rare cases," its coronavirus vaccine can lead to a...
AstraZeneca admits 'very rare' side effect of COVID vaccine in UK court Ruchika Sharma30 April 2024 6:00 PM ISTLondon: AstraZeneca (AZ), a pharmaceutical giant headquartered in the UK, has acknowledged that in "very rare cases," its coronavirus vaccine can...
SII boosts cervical cancer shots supply ahead of govt mass drive Ruchika Sharma4 March 2024 2:43 PM ISTPoonawalla expects the vaccine to be "substantially, probably eight times, cheaper" when supplied to the government.
WHO adds SII-Oxford University Malaria vaccine to its list of prequalified vaccines Ruchika Sharma23 Dec 2023 3:00 PM ISTThe prequalification of the world's second malaria vaccine, developed by Oxford University and manufactured by Serum Institute of India, is poised to...
Serum Institute-Oxford University malaria vaccine bags WHO recommendation Ruchika Sharma3 Oct 2023 12:30 PM ISTThe R21/Matrix-M malaria vaccine is an easily deployable vaccine that can be manufactured at mass scale and modest cost, enabling as many as hundreds...
Govt approves export of Serum Institute BCG vaccine to Canada Ruchika Sharma25 July 2023 1:30 PM ISTThe product is for intravesical instillation and is available from the Serum Institute in 40 mg and 80 mg presentations, the sources said.
WHO prequalifies SII Multivalent meningococcal meningitis vaccine Ruchika Sharma13 July 2023 2:10 PM ISTMenFive is approved by WHO for use in individuals 1 through 85 years of age and will initially be available for use in reactive vaccine campaigns for...
Delete defamatory content against Serum Institute of India: Bombay HC directs two individuals Ruchika Sharma6 Jun 2023 12:35 PM ISTThe suit said the defendants had also been posting incorrect information that implied the Covishield vaccine was the cause of deaths of multiple...
Serum Institute of Life Sciences to double investment in Biocon unit to Rs 2457 crore Ruchika Sharma25 April 2023 12:30 PM ISTUnder new terms of the alliance, it would pump in USD 150 million after converting a loan to Biocon Pharma Ltd into equity in Biocon Biologics Ltd,...
Serum Institute has produced five to six million Covovax doses: Adar Poonawalla Ruchika Sharma24 April 2023 1:30 PM ISTCovovax is the only COVID vaccine made in India which is approved in the US and Europe. Currently, the demand is very small, Poonawalla said.
